HIV Phenotype Tests

Medical Advocates
HIV Drug Monitoring

Phenotype Testing for HIV Drug
Resistance
General Reports
Efficacy
Phenotype/Genotype Comparison Studies
Phenotype Comparison Studies
Brand Index

ARV Resist Monitoring Main New/Newsworthy Home Page

Last Update: May 24, 2008
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

General Reports

Journal Papers, Abstracts, and Commentaries

A randomized, prospective study of phenotype susceptibility testing versus
standard of care to manage antiretroviral therapy: CCTG 575.
Haubrich RH, Kemper CA, Hellmann NS, et al
AIDS. 2005 Feb 18;19(3):295-302.
Abstract

Efficacy

Journal Papers, Abstracts, and Commentaries

Comparison of a Rule-Based Algorithm with a Phenotype-Based Algorithm for the Interpretation of HIV
Genotypes in Guiding Salvage Regimens in HIV-Infected Patients by a Randomized Clinical Trial: The
Mutations and Salvage Study.
Gianotti N, Mondino V, Rossi MC, et al
Clin Infect Dis. 2006 May 15;42(10):1470-80.
Abstract

Development and evaluation of a phenotypic assay monitoring resistance formation
to protease inhibitors in HIV-1-infected patients.
Gehringer H, Von der Helm K, Seelmeir S, et al.
J Virol Methods 2003 May;109(2):143-52
Abstract

Conference Reports, Abstracts, and Posters

1st European HIV Drug Resistance Workshop

PDF POSTER
The VirtualPhenotype : A Quantitative Prediction Of HIV Drug Susceptibility From
Viral Genotype
L Bacheler, H van Marck, H Vermeiren, et al
Poster

Phenotype/Genotype Comparison Studies

Conference Reports, Abstracts, and Posters

POSTER
Discrepant results between antiretroviral resistance mutations patterns by genotypic
analysis (Stanford HIV-SEQ program) and virtual phenotype (VircoNET)
Pérez-Alvarez L, Carmona R, Muñoz M. et al
(1st European HIV Drug Resistance Workshop)
PDF Poster

Phenotype Comparison Studies

Journal Papers, Abstracts, and Commentaries

A Comparative Evaluation of the Automated Roche Taqman Realtime Quantitative HIV 1 RNA
PCR Assay with the Roche Amplicor V1.5 Conventional PCR Assay.
Oliver AR, Pereira SF, Clark DA.
J Clin Microbiol. 2007 Sep 5;
Abstract

Comparison of the precision and sensitivity of the Antivirogram and PhenoSense HIV drug
susceptibility assays.
Zhang J, Rhee SY, Taylor J, Shafer RW.
J Acquir Immune Defic Syndr. 2005 Apr 1;38(4):439-44.
Abstract

Real Versus Virtual Phenotype to Guide Treatment in Heavily Pretreated Patients:
48-Week Follow-Up of the Genotipo-Fenotipo di Resistenza (GenPheRex) Trial
Mazzotta F, Caputo SL, Torti C, et al
J Acquir Immune Defic Syndr 2003 Mar 1;32(3):268-80
Abstract

Cost/Benefit Studies

Select Phenotype Outcome Studies

Journal Papers, Abstracts, and Commentaries

Comparative analysis of two commercial phenotypic assays for drug susceptibility
testing of human immunodeficiency virus type 1.
Qari SH, Respess R, Weinstock H, et al.
J Clin Microbiol 2002 Jan;40(1):31-5
Abstract

Conference Reports, Abstracts, and Posters

1st European HIV Drug Resistance Workshop

POWERPOINT PRESENTATION
Quantitative assessment of resistance to fusion inhibitors in a replicative Phenotyping
assay.
V Brondani, F Hamy, T Klimkait
Presentation

Brand Index

Tibotec Virco (VirtualPhenotype , Antivirogram)

Manufacturer's Information

VirtualPhenotype

Journal Papers, Abstracts, and Commentaries

Comparison of the Precision and Sensitivity of the Antivirogram and PhenoSense
HIV Drug Susceptibility Assays.
Zhang J, Rhee SY, Taylor J, Shafer RW.73
J Acquir Immune Defic Syndr. 2005 Apr 1;38(4):439-444
Abstract

Conflicting interpretations of the prevalence of mutations associated with drug resistance
in antiviral naive HIV-1 patients with acute and chronic infection.
Re MC, Monari P, Bon I,
Int J Antimicrob Agents. 2004 Feb;23(2):164-8.
Abstract

PhenoSense

ARV Resist Monitoring

Main New/Newsworthy

Home Page

Genotype Testing for HIV Drug Resistance